Immunoscore System for Predicting Clinical Outcome of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors

We conducted this study to determine whether immunoscore system (IS) predicts survival in patients with metastatic renal cell carcinoma (mRCC). A total of 218 mRCC patients treated with sunitinib or sorafenib in Zhongshan Hospital, Fudan University were recruited during 2007-2017, retrospectively. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jia-Xi, Chen, Xiang, Xi, Wei, Zhu, Yan-Jun, Wang, Hang, Hu, Xiao-Yi, Guo, Jian-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277607/
https://www.ncbi.nlm.nih.gov/pubmed/30519309
http://dx.doi.org/10.7150/jca.27408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277607/
https://www.ncbi.nlm.nih.gov/pubmed/30519309
http://dx.doi.org/10.7150/jca.27408

Ejemplares similares